Pictet Asset Management (UK)’s Audentes Therapeutics, Inc BOLD Stock Holding History

Pictet Asset Management (UK)’s Portfolio BOLD Stock Details BOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-100,938	Closed	-$6.04M	–	1191
2019 Q4	$6.04M	Buy	100,938 +13,930	+16%	+$523K	0.01%	718
2019 Q3	$2.44M	Sell	87,008 -321,999	-79%	-$11M	0.01%	832
2019 Q2	$15.5M	Buy	409,007 +7,708	+2%	+$296K	0.03%	442
2019 Q1	$15.7M	Buy	401,299 +101,618	+34%	+$2.91M	0.03%	450
2018 Q4	$6.39K	Buy	299,681 +125,852	+72%	+$3.25M	0.02%	602
2018 Q3	$6.88M	Buy	+173,829	New	+$6.48M	0.01%	653

Pictet Asset Management (UK)'s BOLD Position: Q1 2020 in Review

Pictet Asset Management (UK) sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 100,938 shares — an estimated $6.04M sold.

Pictet Asset Management (UK) first reported a position in BOLD in Q3 2018 and held it in 6 quarters. The position peaked at $15.7M in Q1 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

Pictet Asset Management (UK) reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
Pictet Asset Management (UK) sold 100,938 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $6.04M.
Pictet Asset Management (UK) first reported a position in Audentes Therapeutics, Inc in Q3 2018 and held it in 6 quarters.
Pictet Asset Management (UK)'s Audentes Therapeutics, Inc position peaked at $15.7M in Q1 2019.
0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on Pictet Asset Management (UK)'s 13F filing for Q1 2020, filed 13 May 2020.